DE602006011888D1 - Verfahren zur untersuchung von substanzen gegen krebs, satz oder ausrüstung zur umsetzung des verfahrens - Google Patents

Verfahren zur untersuchung von substanzen gegen krebs, satz oder ausrüstung zur umsetzung des verfahrens

Info

Publication number
DE602006011888D1
DE602006011888D1 DE602006011888T DE602006011888T DE602006011888D1 DE 602006011888 D1 DE602006011888 D1 DE 602006011888D1 DE 602006011888 T DE602006011888 T DE 602006011888T DE 602006011888 T DE602006011888 T DE 602006011888T DE 602006011888 D1 DE602006011888 D1 DE 602006011888D1
Authority
DE
Germany
Prior art keywords
investigation
implementing
procedure
equipment
against cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006011888T
Other languages
English (en)
Inventor
Pierre Roux
Toledo Marion De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE602006011888D1 publication Critical patent/DE602006011888D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
DE602006011888T 2005-06-14 2006-06-14 Verfahren zur untersuchung von substanzen gegen krebs, satz oder ausrüstung zur umsetzung des verfahrens Active DE602006011888D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0551616A FR2886942A1 (fr) 2005-06-14 2005-06-14 Procede pour le criblage de substances anti-cancereuses, trousse ou kit pour la mise en oeuvre du procede
PCT/FR2006/050561 WO2006134305A2 (fr) 2005-06-14 2006-06-14 Procede pour le criblage de substances anti-cancereuses ; trousse ou kit pour la mise en oeuvre du procede

Publications (1)

Publication Number Publication Date
DE602006011888D1 true DE602006011888D1 (de) 2010-03-11

Family

ID=36177712

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006011888T Active DE602006011888D1 (de) 2005-06-14 2006-06-14 Verfahren zur untersuchung von substanzen gegen krebs, satz oder ausrüstung zur umsetzung des verfahrens

Country Status (8)

Country Link
US (2) US8062859B2 (de)
EP (1) EP1891443B1 (de)
AT (1) ATE456052T1 (de)
CA (1) CA2611828C (de)
DE (1) DE602006011888D1 (de)
ES (1) ES2339806T3 (de)
FR (1) FR2886942A1 (de)
WO (1) WO2006134305A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
WO2015189236A1 (en) * 2014-06-11 2015-12-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for reducing cd95-mediated cell motility

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR034897A1 (es) * 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
US20050089896A1 (en) * 2003-02-18 2005-04-28 Roy Frans V. Method to control tumor progression and invasiveness
JP2006515623A (ja) * 2003-01-13 2006-06-01 セダーズ−シナイ メディカル センター 化学療法剤としてのパリカルシトール
US20090305963A1 (en) * 2005-01-19 2009-12-10 Sukhatme Vikas P Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis

Also Published As

Publication number Publication date
CA2611828C (fr) 2016-08-02
US20090162874A1 (en) 2009-06-25
US20120107837A1 (en) 2012-05-03
WO2006134305A3 (fr) 2007-03-01
CA2611828A1 (fr) 2006-12-21
WO2006134305A2 (fr) 2006-12-21
ES2339806T3 (es) 2010-05-25
FR2886942A1 (fr) 2006-12-15
EP1891443B1 (de) 2010-01-20
EP1891443A2 (de) 2008-02-27
US8062859B2 (en) 2011-11-22
ATE456052T1 (de) 2010-02-15

Similar Documents

Publication Publication Date Title
IL188599A0 (en) Methods and substances for isolating microrna
EA201491833A1 (ru) Основанные на клетках перекрестные анализы и их применение
EP3779436A3 (de) Verfahren zur erzeugung von ph/ionischen konzentrationsgradienten in der nähe von elektrodenoberflächen zur modulation von biomolekularen wechselwirkungen
MX2012001000A (es) Metodo y kit para la deteccion de un microorganismo.
WO2010019414A3 (en) Detecting nucleic acid
WO2011106738A3 (en) Use of tcr clonotypes as biomarkers for disease
EA201390638A8 (ru) Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения
WO2009114185A3 (en) Methods and compositions for translational profiling and molecular phenotyping
WO2010003043A3 (en) Signet ring cell detector and related methods
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
NZ587750A (en) Molecular diagnosis and classification of malignant melanoma
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
ATE403151T1 (de) Trägerplatte zur durchführung funktioneller tests an biologischen zellen sowie verfahren zur beschichtung der trägerplatte
AU2017248682A1 (en) Method for detecting and/or characterising tumour cells and associated apparatus
WO2008090664A1 (ja) Ｄｎａタグによる生物の同定方法
BR112019006862A2 (pt) dispositivo de análise e método para testagem de uma amostra
CL2012002871A1 (es) Metodo para identificar una población de celulas tr1 en reposo que comprende la deteccion de la expresion en la superficie celular de los marcadores cd4, cd25, cd127 y cd62l; poblacion aislada de celulas tr1; metodo para disminuir una poblacion de celulas tr1; kit para identificar o aislar una poblacion de celulas tr1 en reposo y/o activadas; composicion farmaceutica que comprende una poblacion de celulas tr1 en reposo y/o activadas.
WO2012083274A3 (en) Methods for diagnosis, prognosis and methods of treatment
WO2018013678A3 (en) Molecular markers and methods for sample analysis via mass spectrometry
MX2016014359A (es) Antigeno e de hepadnavirus marcado y su uso en el tamizado de sustancias antivirales.
DE602006011888D1 (de) Verfahren zur untersuchung von substanzen gegen krebs, satz oder ausrüstung zur umsetzung des verfahrens
MX2021014335A (es) Metodos para detectar un nivel de h. pylori en una muestra fecal.
ATE531821T1 (de) Verfahren und vorrichtung zur beurteilung des vorliegens oder nichtvorliegens einer krebszelle
CL2011003063A1 (es) Metodo de alto rendimiento para la deteccion de la presencia de dos o mas proteinas de interes con secuencias de aminoacidos conocidas en una muestra de planta, y procedimiento para mantener el genotipo de una variedad de la planta transgenica.
MX2012000041A (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition